Biotechnology | FDA | Oncology | Therapeutics
FDA approves first cancer drug based on Broad Institute science
On Nov. 20, 2025, the US Food and Drug Administration (FDA) has approved the first cancer drug based…
Biotechnology | Cardiology | Clinical Research | CRISPR | Disease | FDA | Genomics | HIV | Infectious Disease | Influenza | Nanotechnology | Neurology | NIH | Oncology | Organ Transplant | Rare Disease | Stem Cell | Therapeutics | U.S. Congress | Vaccine | Women's Health
Halted NIH Clinical Trials List Reveals Slashed Treatments for Cancer, COVID and Minority Health
On Nov. 20, 2025, the National Institutes of Health (NIH) has canceled funding for at least 383 clinical…
CPRIT approves $154 million in new cancer research and prevention awards, surpasses $4 billion total
On Nov. 19, 2025, the governing board of the Cancer Prevention and Research Institute of Texas (CPRIT) approved…
GRAIL PATHFINDER 2 Results Show Galleri ® Multi-Cancer Early Detection Blood Test Increased Cancer Detection
On Oct. 18, 2025, GRAIL announced that positive performance and safety results from its registrational PATHFINDER 2 study…
Disease | Environmental | WHO
WHO Reports 1 in 5 adults still addicted to tobacco
On Oct. 6, 2025, the World Health Organization (WHO) reported world is smoking less, but the tobacco epidemic…
Exact Sciences Launches Cancerguard™, First-of-Its-Kind Multi-Cancer Early Detection Blood Test
On Sept. 10, 2025, Exact Sciences announced the launch of the Cancerguard™ test, a new multi-cancer early detection…
Study Led by Roswell Park Finds GLP-1 Receptor Agonists Improve Lung Cancer Outcomes
On Sept. 8, 2025, research led by Sai Yendamuri, MD, MBA, FACS, Chair of Thoracic Surgery at Roswell…
Study reveals a novel immune-based therapy that may be effective in hard-to-treat lung cancers
On Jul. 24, 2025, a team of researchers from TGen, part of City of Hope, and Baylor Scott…
Air Pollution May Contribute to Development of Lung Cancer in Never-smokers, New Study Finds
On Jul. 2, 2025, a study jointly led by researchers at the University of California San Diego and…
Biotechnology | Disease | FDA | Oncology
US FDA approves AbbVie’s drug for a type of lung cancer
On May 14, 2025, The U.S. Food and Drug Administration (FDA) has approved AbbVie’s drug to treat adults…
Origins of common lung cancer that affects smokers discovered
On May 2, 2025, researchers at the Wellcome Sanger Institute, UCL, and the University of Cambridge announced they…
Tumour DNA in the blood can predict lung cancer outcome
On Jan. 13, 2025, scientists from the Francis Crick Institute, UCL, UCLH and Personalis announced they have found…
Microplastics in the Air May Be Leading to Lung and Colon Cancers
On Dec. 18, 2024, researchers from the UC San Francisco released a study showing that tires and degrading…
Biotechnology | Disease | FDA | Oncology | Radiology | Therapeutics
FDA approved AstraZeneca’s Imfinzi for limited-stage small cell lung cancer
On Dec. 4, 2024, The U.S. Food and Drug Administration (FDA) announced approved of AstraZeneca’s blockbuster drug Imfinzi…
Artificial intelligence improved lung cancer diagnosis
On Aug. 23, 2024, A team of researchers from the University of Cologne announced they had created a…
Global cancer deaths among men projected to increase by 93% by 2050
On Aug. 15, 2024, a study published in the journal Cancer projected an alarming increase in cancer cases and deaths…
largest population-based study to date supported the survival benefits of immunotherapy for people with metastatic non-small cell lung cancer
On Jul. 29, 2024, a team led by the Barbara Ann Karmanos Cancer Institute and the Wayne State…
Biotechnology | Disease | Environmental | EPA | Therapeutics
U.S. Environmental Protection Agency finalized ban on ongoing uses of asbestos to protect people from cancer
On Mar. 18, 2024, the U.S. Environmental Protection Agency (EPA) announced a final rule to prohibit ongoing uses…
Biotechnology | Disease | Medicine | NIH | Ophthalmogy | Therapeutics
NIH study confirmed benefit of supplements for slowing age-related macular degeneration
On Jun. 2, 2022, the National Institutes of Health (NIH) reported that the Age-Related Eye Disease Studies (AREDS…
Biotechnology | Diagnostics | Disease | FDA | Oncology | Radiology | Therapeutics
FDA approved Roche’s Tecentriq as adjuvant treatment for certain people with early non-small cell lung cancer
On Oct. 15, 2021, Roche announced that the U.S. Food and Drug Administration (FDA) had approved Tecentriq (atezolizumab)…
Biotechnology | Diagnostics | Disease | Environmental | Genomics | NIH | Oncology
NIH study illuminated origins of lung cancer in never smokers
On Sept. 6, 2021, a genomic analysis of lung cancer in people with no history of smoking has…
Biotechnology | Diagnostics | Disease | Oncology | Radiology | Therapeutics
Rapid decrease in lung cancer and melanoma deaths lead overall continued decline in cancer death rate
On Jul. 8, 2021, the National Institutes of Health (NIH) reported that the overall cancer death rates continue…
Biotechnology | Diagnostics | Disease | FDA | Oncology | Radiology | Therapeutics
FDA approved LUMAKRAS for patients with KRAS G12C-mutated locally advanced or metastatic non-small cell lung cancer
On May 28, 2021, Amgen announced that the U.S. Food and Drug Administration (FDA) had approved LUMAKRAS (sotorasib)…
Biotechnology | Diagnostics | Disease | FDA | Oncology | Radiology | Therapeutics
FDA approved first targeted therapy for subset of non-small cell lung cancer
On May 21, 2021, the the U.S. Food and Drug Administration (FDA) approved Rybrevant (amivantamab-vmjw) as the first…
Biotechnology | Diagnostics | Disease | Oncology | Radiology | Therapeutics
American Cancer Society reported largest one-year drop in cancer mortality from 1991-2017
On Jan. 8, 2021, the American Cancer Society reported that the death rate from cancer in the U.S….
Biotechnology | Diagnostics | Disease | FDA | Oncology | Radiology | Therapeutics
FDA approved first adjuvant therapy for most common type of lung cancer
On Dec. 18, 2020, the the U.S. Food and Drug Administration (FDA) approved AstraZeneca’s Tagrisso (osimertinib) as the…
Biotechnology | Diagnostics | Disease | FDA | Oncology | Therapeutics
FDA approved first targeted therapy to treat aggressive form of lung cancer
On May 6, 2020, the U.S. Food and Drug Administration (FDA) approved Tabrecta (capmatinib) for the treatment of…
Phase 3 trial of Libtayo (cemiplimab) as monotherapy for first-line advanced non-small cell lung cancer stopped early due to highly significant improvement in overall survival
On Apr. 27, 2020, Regeneron and Sanofi announced the primary endpoint of overall survival was met in a…
Biotechnology | Diagnostics | Disease | Oncology | Radiology | Vaccine
Winship Cancer Institute awarded prestigious Lung Cancer SPORE grant from NCI
On Jun. 10, 2019, the Winship Cancer Institute was awarded a five-year, $9.7 million Specialized Program of Research…
The National Cancer Institute awarded a $10.7 million grant to Abramson Cancer Center to study CAR T cells in solid tumors
On Oct. 22, 2018, the National Cancer Institute (NC) awarded a $10.7 million five year grant to Abramson…